
Lycorine chloride
CAS No. 2188-68-3
Lycorine chloride( —— )
Catalog No. M18244 CAS No. 2188-68-3
Lycorine chloride is extracted from Lycoris radiata.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 35 | Get Quote |
![]() ![]() |
50MG | 58 | Get Quote |
![]() ![]() |
100MG | 87 | Get Quote |
![]() ![]() |
500MG | 214 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLycorine chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLycorine chloride is extracted from Lycoris radiata.
-
DescriptionLycorine chloride is extracted from Lycoris radiata.
-
In VitroLycorine hydrochloride (0-25 μM; 48 hours; C8161 cells) treatment markedly suppresses the expression of vascular endothelial (VE)-cadherin in a dose-dependent manner and also slightly diminishes the expression of Sema4D in C8161 cells. However, the expression of the other six genes is not affected.Lycorine hydrochloride (0-25 μM; 48 hours; C8161 cells) treatment markedly reduces VE-cadherin protein levels in C8161 cells in a dose-dependent fashion.RT-PCR Cell Line:C8161 cells Concentration:0 μM, 1.56 μM, 3.13 μM, 6.25 μM, 12.5 μM, 25 μM Incubation Time:48 hours Result:Markedly suppressed the expression of VE-cadherin in a dose-dependent manner and also slightly diminished the expression of Sema4D in C8161 cells.Western Blot Analysis Cell Line:C8161 cells Concentration:0 μM, 1.56 μM, 3.13 μM, 6.25 μM, 12.5 μM, 25 μM Incubation Time:48 hoursResult:Markedly reduced VE-cadherin protein levels in C8161 cells in a dose-dependent fashion.
-
In VivoLycorine hydrochloride (0-15 μg; subcutaneous injection; for 14 days; BALB/C nude mice) treatment has an inhibitory effect on melanoma cell-mediated tumor vasculogenic mimicry. Animal Model:6- to 8-week-old BALB/C nude mice Dosage:0 μg, 7.5 μg, 15 μg Administration:Subcutaneous injection; for 14 days Result:Showed an inhibitory effect on melanoma cell-mediated tumor vasculogenic mimicry.
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2188-68-3
-
Formula Weight323.17
-
Molecular FormulaC16H18ClNO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 31 mg/mL; 95.75 mM
-
SMILESC1CN2Cc3cc4c(cc3[C@H]3[C@H]2C1=C[C@@H]([C@H]3O)O)OCO4.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu M, et al. Oncotarget. 2015 Jun 20;6(17):15348-61.
molnova catalog



related products
-
DO-IN-2
IDO-IN-2 is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
-
Riamilovir
Riamilovir is a broad-spectrum antiviral drug candidate.
-
Cyclosporin C
Cyclosporin C is a fungal metabolite against filamentous phytopathogenic fungi. Cyclosporin C has antifungal, antiviral, and immunosuppressant properties.